LATEST ALERTS
This report provides a detailed analysis of the current regulatory framework in place in Colombia for cannabis, hemp and other cannabinoids including CBD
Many state governments are now offering an alternative to adults who wish to consume cannabis outside of their home. This report examines the regulation of these consumption spaces in states that have legalised recreational cannabis
This report provides detailed analysis of the regulatory framework in place in Canada for CBD and other cannabinoids, hemp, and cannabis (both recreational and medical)
This report provides detailed analysis around the current regulatory framework in place on a federal level in the US for hemp, CBD, other cannabinoids as well medical and recreational cannabis
This report provides a detailed analysis of the current regulatory framework in place for hemp, CBD and cannabis in Panama, covering all policy areas
This report provides a detailed overview of the current regulatory framework in place in Chile for hemp and cannabis, as well as CBD, IHDCs, and medical and recreational cannabis
This snapshot offers an overview of Canada’s medical cannabis market and its regulations
This report provides a detailed overview of the regulatory framework in place for CBD, hemp and cannabis, covering everything from processing and cultivation to finished products, import/export and the country’s cannabis regime
This report offers a comprehensive overview of the current regulatory framework in place in Peru for hemp, CBD and other cannabinoids, as well as medical and recreational cannabis
This report examines the basic regulatory framework for the most popular IHDC product categories and identifies the IHDC product that is most likely to be allowed in Europe
This tracker outlines the ballot initiatives in the US that are likely to appear on ballot this November and will be updated periodically to keep the information up to date
US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling review.
This report provides a detailed overview of the regulatory framework in place in Uruguay for hemp, cannabis and CBD
This report examines which US states allow the sale of intoxicating hemp-derived cannabinoid (IHDC) products in licensed dispensaries and which states have dispensaries offering them – regardless of whether they are permitted – to demonstrate the states that effectively deter IHDC sales in dispensaries
Intoxicating hemp-derived cannabinoids (IHDC) have been major disruptors in the CBD and legal cannabis sectors in the US for some time now. This report details and analyses recent developments in their regulation
Mexico is set to become a major global market for cannabis and CBD, but its potential has been stymied by congressional inaction
This report offers a comprehensive overview of the current regulatory framework in Paraguay for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
The hemp and cannabis legal framework in Colombia has rapidly evolved over the last few months. This report offers an overview of the current regulatory regime
This regulatory report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy
This report offers a comprehensive overview of the current regulatory framework for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
This report covers the regulatory framework for CBD, hemp and cannabis in Brazil
This report covers, state by state, the widely differing tax policies for medical cannabis in the US
Covers: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama. Overall, the region is restrictive on hemp and cannabis, with exceptions being Belize, Costa Rica and Panama
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries
This report offers a comprehensive overview of California’s Assembly Bill (AB) 45, which is the culmination of years of legislative attempts to regulate hemp-derived products in the state
Some sellers of intoxicating cannabinoid products claim legality under the 2018 US Farm Bill. CBD-Intel believes that many hemp-derived cannabinoids do not violate federal controlled substance law
Chile has maintained a rather restrictive approach towards hemp and CBD. It has only recently allowed medicinal use of cannabis-based products, but there are still many legal grey areas as a consequence of the lack of regulation
This regulatory report examines which of the 36 US states that have legalised medical and/or recreational cannabis sales allow for home deliveries of cannabis products
This report covers, state by state, the question of whether each US state allows the sale of hemp-derived CBD vaping products and on what legal terms
This report examines US federal and all state law as it pertains to CBD in pet food
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
